DR. MICHAEL TAVDY M.D. NPI 1720016793

NPI Details

DR. Michael Tavdy, M.D. is an internal medicine in Brooklyn, NY with 46 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Michael Tavdy, M.D. NPI is 1720016793. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2705 MERMAID AVE
BROOKLYN, NY
ZIP 11224-005
Phone: (718) 265-2222
Fax: (718) 333-1023

The NPI 1720016793 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month (HCPCS:99491)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Face-to-face behavioral counseling for obesity, 15 minutes (HCPCS:G0447)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Injection, calcium gluconate, per 10 ml (HCPCS:J0610)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes (HCPCS:G0446)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS:93010)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Injection of anesthetic agent and/or steroid into other nerve or branch (HCPCS:64450)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Complete ultrasound scan of abdomen (HCPCS:76700)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Exam of neurobehavioral status, first hour (HCPCS:96116)
• Injection of drug or substance into vein (HCPCS:96374)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient home visit, typically 25 minutes (HCPCS:99348)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Injection, metoclopramide hcl, up to 10 mg (HCPCS:J2765)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Ultrasound study of arm or leg veins with compression and maneuvers (HCPCS:93970)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/29/2006 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.